Physician profile
Christopher James Jones
NPI 1750615027
$137,985.44
in general payments reported to CMS, 2019-2025
5 companies · $80K in 2025
The $80K reported for 2025 was more than what 99% of Prosthodontics providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,738 · 2020: $137 · 2021: $300 · 2022: $323 · 2023: $17K · 2024: $38K · 2025: $80K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $90K · Travel and Lodging: $42K · Food and Beverage: $1,906 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,067 · Entertainment: $112 · Education: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $89,850.00 |
| Travel and Lodging | $42,452.01 |
| Food and Beverage | $1,905.76 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,067.46 |
| Entertainment | $111.75 |
| Education | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $137,114.36 | 2019-2025 | |
| Nobel Biocare USA | $419.75 | 2019-2023 | Nobelactive |
| Henry Schein, INC. | $407.99 | 2019-2024 | 3shape Trios A/S-Trios3 Pen W/Move+, Dentrix Ascend Imaging |
| Gc America INC. | $28.82 | 2019-2020 | |
| Kerr Corporation | $14.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.